LEWICKI JOHN A. (Chief Scientific Officer) sold 33.2% of their position (24.22K shares) of MEREO BIOPHARMA GROUP PLC on the open market
Open‑market sale worth $84.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/27/2024ACC: 0000950170-24-078468
Officer· Chief Scientific Officer
Since Feb 2026
-24.22K
Net shares
Net seller
$84.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
24.22K disposed
Non-Derivative Transactions2
American Depositary Shares representing Ordinary Shares
Direct
Shares
−7.42K
Price / share
$3.69
Trade value
$27.39K
% of position
10.2%
6/25/2024
73K→65.59K
American Depositary Shares representing Ordinary Shares
Direct
Shares
−16.81K
Price / share
$3.39
Trade value
$57.03K
% of position
25.6%
6/26/2024
65.59K→48.78K
Total
Net shares
−24.22K
Net value
-$84.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares representing Ordinary Shares Direct | 6/25/2024 | S · Sale | −7.42K | $3.69 | $27.39K | 10.2% | 73K | 65.59K |
| American Depositary Shares representing Ordinary Shares Direct | 6/26/2024 | S · Sale | −16.81K | $3.39 | $57.03K | 25.6% | 65.59K | 48.78K |
| Total | −24.22K | -$84.43K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
American Depositary Shares representing Ordinary Shares
IndirectShares owned14.20K
Total
14.20K indirect14.20K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| American Depositary Shares representing Ordinary Shares | 14.20K | Indirect |
| Total | 14.20K | 14.20K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported